Phase 1 repolarization rate defines Ca(2+) dynamics and contractility on intact mouse hearts

第一阶段复极化速率决定了完整小鼠心脏的Ca²⁺动态和收缩力。

阅读:1

Abstract

In the heart, Ca(2+) influx through L-type Ca(2+) channels triggers Ca(2+) release from the sarcoplasmic reticulum. In most mammals, this influx occurs during the ventricular action potential (AP) plateau phase 2. However, in murine models, the influx through L-type Ca(2+) channels happens in early repolarizing phase 1. The aim of this work is to assess if changes in the open probability of 4-aminopyridine (4-AP)-sensitive Kv channels defining the outward K(+) current during phase 1 can modulate Ca(2+) currents, Ca(2+) transients, and systolic pressure during the cardiac cycle in intact perfused beating hearts. Pulsed local-field fluorescence microscopy and loose-patch photolysis were used to test the hypothesis that a decrease in a transient K(+) current (I(to)) will enhance Ca(2+) influx and promote a larger Ca(2+) transient. Simultaneous recordings of Ca(2+) transients and APs by pulsed local-field fluorescence microscopy and loose-patch photolysis showed that a reduction in the phase 1 repolarization rate increases the amplitude of Ca(2+) transients due to an increase in Ca(2+) influx through L-type Ca(2+) channels. Moreover, 4-AP induced an increase in the time required for AP to reach 30% repolarization, and the amplitude of Ca(2+) transients was larger in epicardium than endocardium. On the other hand, the activation of I(to) with NS5806 resulted in a reduction of Ca(2+) current amplitude that led to a reduction of the amplitude of Ca(2+) transients. Finally, the 4-AP effect on AP phase 1 was significantly smaller when the L-type Ca(2+) current was partially blocked with nifedipine, indicating that the phase 1 rate of repolarization is defined by the competition between an outward K(+) current and an inward Ca(2+) current.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。